SOBEL ALAN D. reported 1 transaction at CYTOSORBENTS CORP
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2025ACC: 0001104659-25-017618
0.00
Net shares
Net seller
$24.8K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
21.95K acquired · 21.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.95K
Price / share
$1.13
Trade value
$24.80K
% of position
17.7%
2/24/2025
123.81K→145.76K
Total
Net shares
+21.95K
Net value
$24.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | O · O | +21.95K | $1.13 | $24.80K | 17.7% | 123.81K | 145.76K |
| Total | +21.95K | $24.80K | ||||||
Derivative Transactions1
Series A Right Warrants (right to buy)
Direct
Converts to
Common Stock
21.95K shares
Shares
−21.95K
Strike price
1.13
Held after
0.00
Exercisable
—
2/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Right Warrants (right to buy) Direct | Common Stock21.95K shares | 2/24/2025 | O · O | −21.95K | 1.13 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported